Jiangsu Nhwa Pharmaceutical Co Ltd

002262

Company Profile

  • Business description

    Jiangsu Nhwa Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in the manufacturing of APIs and dosages. The company markets its pharmaceutical products in four main categories: anesthetic drugs, such as midazolam injection and etomidate fat emulsion injection; psychiatric drugs, including risperidone tablets and related products; neurological drugs, such as gabapentin capsules; and bulk pharmaceuticals, including fenofibrate and miconazole nitrate. In addition, the company is also involved in the pharmaceuticals trading business.

  • Contact

    No. 31, Longhu West Road
    Enhua Technology Building
    Economic and Technological Development Zone
    Xuzhou221009
    CHN

    T: +86 51687767115

    https://www.nhwa-group.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    5,923

Stocks News & Analysis

stocks

Meta earnings: Strong end to 2025 as AI monetization begins to show

Investors please with latest results.
stocks

Why doesn’t the market like the earnings from this US tech giant?

Good quarter with AI demand ramping.
stocks

Our Tesla fair value increases meaningfully

Progress on Robotaxi and Optimus shows real world AI growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,157.60101.60-1.10%
CAC 408,071.364.680.06%
DAX 4024,309.46513.33-2.07%
Dow JONES (US)49,071.5655.960.11%
FTSE 10010,171.7617.330.17%
HKSE27,469.82498.27-1.78%
NASDAQ23,685.12172.33-0.72%
Nikkei 22553,326.1749.43-0.09%
NZX 50 Index13,423.1874.570.56%
S&P 5006,969.019.02-0.13%
S&P/ASX 2008,863.1092.00-1.03%
SSE Composite Index4,108.4649.52-1.19%

Market Movers